Global Diabetic Footwear Market Outlook, 2029

Diabetes is a chronic condition that affects millions of people worldwide, and its complications can extend to various parts of the body, including the feet. Diabetic foot problems can arise due to nerve damage (neuropathy) and poor blood circulation, making it crucial for individuals with diabetes to pay special attention to their footwear choices. Diabetic neuropathy and peripheral arterial disease are common complications that can lead to foot problems among individuals with diabetes. Neuropathy causes a loss of sensation in the feet, making it difficult for individuals to detect injuries, cuts, or blisters. Additionally, poor blood circulation can slow down the healing process, increasing the risk of infections.

Consequently, even minor foot issues can escalate into serious problems for those with diabetes. The adoption of diabetic footwear has become increasingly crucial in managing the well-being of individuals living with diabetes. As diabetes continues to affect millions globally, understanding the importance of specialized footwear tailored for this population is paramount. With diabetes reaching epidemic proportions worldwide, it has become imperative to address the associated complications, particularly those related to foot health. Diabetes can lead to neuropathy, reduced blood circulation, and a higher risk of infections, all of which significantly impact the feet.

Recognizing the need for specialized footwear is a pivotal step in mitigating these complications and enhancing the overall well-being of individuals with diabetes. This market revenue is attributable to the several factors comprising the development of advanced materials and manufacturing techniques that have improved the quality and functionality of diabetic footwear. Companies are incorporating features such as cushioning, moisture-wicking properties, seamless interiors, and adjustable closures to enhance comfort & reduce the risk of foot complications. Diabetic footwear manufacturers are increasingly focusing on customization and personalization to cater to individual foot conditions.

This includes offering various width and depth options, as well as accommodating orthotic inserts and modifications to meet specific patient needs. Similarly, companies in the diabetic footwear market are collaborating with podiatrists and other healthcare professionals to gain insights into patient needs and to ensure that their products meet medical standards. Such collaborations help in developing effective footwear solutions and establishing credibility within the healthcare community. As a result, technological advancements, customization & personalization, and collaboration with healthcare professionals are augmenting the market revenue.

According to the research report, 'Global Diabetic Footwear Market Outlook, 2029', the market is anticipated to cross USD 10 Billion by 2029, increasing from USD 7.24 Billion in 2023. The market is expected to grow with 6.72% CAGR by 2024-29. Diabetic footwear is designed to address the unique challenges faced by individuals with diabetes, such as neuropathy and poor circulation. These shoes provide extra depth, cushioning, and seamless interiors to minimize the risk of pressure points, ulcers, and infections. By preventing these complications, diabetic footwear contributes to maintaining healthier feet. The comfort features of diabetic shoes, including padded insoles and adjustable closures, make them ideal for daily wear.

This enhanced comfort promotes better mobility, encouraging individuals with diabetes to stay active and engage in regular physical activity, an essential aspect of diabetes management. Diabetes can lead to changes in foot size and shape over time. Diabetic footwear often comes with adjustable closures and extra width to accommodate these changes, ensuring a secure and customized fit. This adaptability is crucial in preventing friction and discomfort. Breathable materials and moisture-wicking properties in diabetic shoes help maintain a dry environment, reducing the risk of fungal infections.

Protecting the feet from infections is vital for individuals with diabetes, as compromised healing abilities can escalate minor issues into more serious complications. By providing a comfortable and supportive foundation for daily activities, diabetic footwear empowers individuals to maintain their independence. The reduced risk of foot problems allows those with diabetes to confidently pursue their daily routines without the fear of potential complications. The growing awareness of the benefits of diabetic footwear is leading to increased consultations with healthcare professionals, including podiatrists and diabetes educators. These experts play a crucial role in guiding individuals toward the most suitable footwear options based on their specific needs and foot conditions.

Market Drivers

• Rising Diabetes Prevalence Worldwide: One of the primary drivers for the global diabetic footwear market is the escalating prevalence of diabetes on a global scale. As the number of individuals diagnosed with diabetes continues to rise, there is a corresponding increase in the demand for specialized products, including diabetic footwear. The footwear industry is responding to this growing market by developing innovative and technologically advanced diabetic shoes to cater to the specific needs of individuals with diabetes.
• Growing Awareness of Foot Health: There is a notable shift in awareness regarding the importance of foot health among individuals with diabetes. Patients and healthcare professionals alike are recognizing the significance of proactive measures to prevent diabetic foot complications. This heightened awareness is driving the adoption of diabetic footwear as a preventive solution. As people become more informed about the potential risks and complications associated with diabetes-related foot problems, they are more likely to invest in appropriate footwear to safeguard their foot health.

Market Challenges

• Limited Insurance Coverage: Despite the evident need for diabetic footwear in managing foot complications related to diabetes, there is a challenge in terms of limited insurance coverage for such specialized products. Many healthcare systems do not provide comprehensive coverage for diabetic footwear, making it a financial burden for some individuals. This obstacle can hinder the widespread adoption of diabetic footwear, especially in regions where access to healthcare resources is limited.
• Affordability and Accessibility: The cost of diabetic footwear can be relatively high due to the specialized materials and design required to meet the unique needs of individuals with diabetes. Affordability becomes a challenge for some patients, leading to potential delays or reluctance in adopting these specialized shoes. Additionally, accessibility may be an issue in certain regions, where individuals may face challenges in finding a variety of diabetic footwear options or reaching stores that offer them.

Market Trends

• Technological Innovations: Advancements in technology are driving significant trends in the diabetic footwear market. Manufacturers are incorporating innovative materials, such as moisture-wicking fabrics, breathable membranes, and pressure-relieving insoles. Smart footwear, equipped with sensors to monitor foot health and detect potential issues, is also emerging as a trend. These technological innovations not only enhance the comfort of diabetic shoes but also contribute to better preventive care.
• Fashionable and Stylish Designs: There is a noticeable shift in the design aesthetics of diabetic footwear. Manufacturers are increasingly focusing on creating stylish and fashionable diabetic shoes that do not compromise on functionality. This trend aims to eliminate the stigma often associated with medical footwear, encouraging individuals with diabetes to embrace and wear their specialized shoes with confidence. As a result, diabetic footwear is becoming more inclusive and aligning with mainstream fashion trends.

COVID-19 Impact

The global lockdowns and restrictions imposed to curb the spread of COVID-19 led to significant disruptions in supply chains. This disruption affected the production and distribution of diabetic footwear, with manufacturers facing challenges in sourcing materials and components. Delays in production and shipment contributed to a shortage of certain products and impacted the ability of companies to meet consumer demand. Economic uncertainties arising from the pandemic led to reduced consumer spending on non-essential items, including specialized footwear. Many individuals faced financial constraints, and purchases of diabetic footwear, which can be relatively more expensive than regular shoes, might have been deferred.

The economic impact influenced buying decisions, with consumers prioritizing essential needs over non-essential items. With lockdowns and social distancing measures in place, there was a notable shift towards online shopping. This change in consumer behavior affected the distribution channels for diabetic footwear, prompting manufacturers and retailers to strengthen their online presence. Companies that already had robust e-commerce platforms were better positioned to adapt to the new normal, while others had to quickly enhance their online capabilities. The pandemic underscored the importance of health and wellness, leading to an increased awareness of preventive measures.

Individuals, particularly those with pre-existing health conditions such as diabetes, became more conscious of the need for proper care. This heightened awareness could have positively influenced the demand for diabetic footwear as part of a broader commitment to overall health and well-being. Due to concerns about exposure to the virus, many individuals delayed non-urgent healthcare appointments, including visits to podiatrists or specialists related to foot health. This delay in seeking professional advice could have impacted the prescription and recommendation of diabetic footwear, as individuals may not have received timely guidance on the importance of these specialized shoes.

The shoes segment held the dominant market share in 2023 attributable to the growing diabetic population, increasing awareness, and the advent of innovative features among others.

The rising prevalence of diabetes globally is a significant driver for the growth of the diabetic shoes segment. According to the World Health Organization (WHO), over 420 Million people worldwide have diabetes, with the majority living in low- and middle-income countries. The demand for specialized footwear that offers comfort and protection will increase significantly as more people are diagnosed with diabetes. There is a growing awareness among diabetic patients about the importance of diabetes care devices to prevent complications such as foot ulcers and neuropathy. This awareness has resulted in a higher demand for diabetic shoes that are specifically designed to provide proper support and reduce the risk of injuries.

Additionally, the diabetic shoes segment has witnessed technological advancements along with innovative features comprising cushioning, breathable materials, and moisture-wicking properties among others. Diabetic shoes are the most common footwear type among individuals with diabetes. Diabetic shoes ensure pressure point reduction, friction minimization, and even weight distribution, effectively safeguarding the feet from developing ulcers and other complications. Diabetic shoes also provide superior arch support and stability, particularly crucial for individuals with neuropathy, a condition that causes numbness and loss of sensation in the feet.

Growing awareness of the importance of diabetic footwear among individuals with diabetes and healthcare professionals is driving an increased demand for specialized shoes. Medical professionals are emphasizing the role of diabetic footwear in preventive foot care. Educational campaigns are highlighting the benefits of these shoes for reducing foot complications. The wide range of options available is increasing awareness of foot care practices. These factors are driving the diabetic footwear market position, and as the number of cases of diabetes rises, the demand for the shoes will also increase.

The neuropathy segment has emerged as a dominant force in the diabetic footwear market owing to the specific challenges and risks associated with diabetic peripheral neuropathy.

Neuropathy, a common complication of diabetes, results in nerve damage that often leads to reduced sensation in the feet. Individuals affected by neuropathy are at a heightened risk of developing foot ulcers, infections, and other complications due to their diminished ability to perceive pain or discomfort. As a result, the demand for diabetic footwear within the neuropathy segment has surged as a preventive measure to mitigate these risks. Manufacturers catering to this segment have responded by designing specialized shoes that address the unique needs of individuals with neuropathy. These shoes typically feature extra depth, soft and seamless interiors, and cushioned insoles to minimize pressure points and reduce the risk of ulcers.

The dominance of the neuropathy segment in the diabetic footwear market is also fueled by the increasing prevalence of diabetes worldwide. With a growing number of individuals diagnosed with diabetes and subsequently experiencing neuropathy, there is a parallel rise in the demand for footwear that provides both comfort and protection. Healthcare professionals and podiatrists often recommend diabetic footwear as an integral part of managing neuropathic conditions, further contributing to the segment's dominance.

The emphasis on early intervention and preventive care in addressing the specific challenges posed by neuropathy positions this segment at the forefront of the diabetic footwear market, reflecting a concerted effort to enhance the overall foot health of individuals managing diabetes and neuropathic complications.

The specialty store distribution channel is a preferred choice by the consumers and healthcare professionals as these shoes require proper fitting and expert guidance before their use, which is difficult with online platforms.

Unlike general retailers, specialty stores focusing on diabetic footwear prioritize a deep understanding of the specific requirements related to foot health in diabetes management. These stores often employ knowledgeable staff and healthcare professionals who can provide personalized assistance, ensuring that customers find the most suitable diabetic footwear for their individual conditions. The complexity of diabetic foot care necessitates a more nuanced approach, and specialty stores are adept at offering a diverse range of diabetic shoes with features such as extra depth, cushioned insoles, and seamless interiors.

The dedicated focus on diabetic footwear in specialty stores enhances the overall customer experience by providing a one-stop-shop for individuals seeking expert guidance and a wide variety of options. Moreover, these stores often collaborate with healthcare professionals, including podiatrists and diabetes educators, creating a holistic ecosystem that prioritizes foot health. The dominance of the specialty store segment is also fueled by the increasing awareness among consumers about the importance of proper foot care in diabetes.

As individuals become more informed about the risks associated with diabetes-related foot complications, they are inclined to seek out specialized solutions offered by these stores. The expertise, personalized service, and specialized product offerings make the specialty store segment an influential player in the diabetic footwear market, reflecting a commitment to addressing the distinct needs of individuals managing diabetes and ensuring their access to high-quality, tailored footwear solutions.

In 2022, the women segment witnessed the maximum revenue share in the market, with an increasing importance on health and wellness, more women are proactively managing chronic conditions like diabetes.

Diabetes affects both genders, but women often experience specific health concerns, such as gestational diabetes and hormonal fluctuations, that can contribute to an increased risk of developing the condition. The growing incidence of diabetes among women has naturally led to a heightened demand for diabetic footwear tailored to their needs. Additionally, women are more prone to conditions like neuropathy and peripheral arterial disease, complications that underscore the importance of proper foot care.

As a result, there is a greater recognition among women with diabetes of the need for specialized footwear to prevent potential foot problems and complications. The dominance of women in the diabetic footwear market is also influenced by their proactive approach to health and wellness. Women, in general, tend to be more health-conscious and are often primary decision-makers regarding family healthcare. This proactive stance towards preventive measures, including the adoption of diabetic footwear, positions women as a key demographic drives the market.

Furthermore, the expanding range of stylish and fashionable diabetic footwear options specifically designed for women has contributed to the increased market share. The integration of comfort, functionality, and style in diabetic shoes has resonated with women, encouraging them to invest in these specialized products as an essential component of their overall health management.

North America is expected dominate the market as well as grow at a steady pace in the diabetic footwear market due to the rise in geriatric population along with launch of improved diabetic footwear.

North America has emerged as a leader in the diabetic footwear market due to a combination of factors that reflect the region's robust healthcare infrastructure, rising prevalence of diabetes, and a growing emphasis on preventive healthcare. The region's well-established healthcare system facilitates early diagnosis and management of diabetes, creating a heightened awareness of the importance of foot care in individuals with the condition. Additionally, North America has witnessed a steady increase in the aging population, a demographic often associated with a higher risk of diabetes. This demographic shift has driven the demand for diabetic footwear, as older individuals are more likely to experience foot-related complications.

Furthermore, the region's high disposable income levels have enabled a greater affordability for specialized healthcare products, including diabetic footwear. The proactive approach to health and wellness in North America has translated into an increased understanding of the significance of preventive measures, leading to a higher adoption rate of diabetic footwear. The prevalence of well-established footwear manufacturers and healthcare professionals who advocate for diabetic foot care further contributes to North America's leadership in the market.

Moreover, the region has witnessed a surge in technological innovations, with companies introducing smart diabetic footwear equipped with sensors and monitoring capabilities. Furthermore, rising concerns regarding adverse effects associated with diabetic disorders among working class population of the U.S. and Canada are projected to have a strong impact. In addition, availability of products with advanced, excellent feet comfort features is expected to remain a favorable factor in the near future.

The leading players in the diabetic footwear market have focused on providing customized solutions to consumers as their key strategies to gain a significant share in the market. Strategies, such as product launch and acquisition, have also helped the key players to gain a significant share in the global diabetic footwear market. The key players engaged in the manufacturing of diabetic footwear across the world are Aetrex Inc., Enovis, Apex Foot Health Industries, LLC, Orthofeet Inc., Propet USA, Inc., 3M, BSN medical GmbH, Siren Care, Intersocks SRL, Sigvaris AG, Simcan Enterprises Inc, ASICS, Kinetec Medical Products Ltd, DARCO International, Inc., Skechers USA, Inc., Drew Shoe Corporation, New Balance Athletics, Inc and Orthofeet Inc.

• In April 2023, Skechers took over Sports Connection Holding, a Scandinavia-based operator of distributor business. This acquisition aimed to broaden the company's customer reach in Europe.
• In November 2023, Orthofeet, Inc. A shuffling gait is a gait type characterized by dragging the feet along the ground or not fully lifting them. There are many causes of shuffling gait patterns. Most commonly, these patterns are associated with health conditions that affect the nervous system, joints, or muscles, like peripheral neuropathy, Parkinson’s disease, or cerebral palsy.
• In May 2022, Anodyne, LLC, a major provider of clinical footwear products most typically prescribed for diabetic patients, announced that HealthEdge Investment Partners, LLC a healthcare-focused private equity fund, had finalized an investment in the company
• In May 2022, Enovis, a global medical technology firm, had acquired 360 Med Care Pty Ltd, an Australia-based orthopaedic startup. The goal is to improve patient outcomes throughout the orthopaedic care process.
• In April 2022, HealthEdge Investment Partners, LLC a healthcare focused private equity fund, had acquired Anodyne, LLC ('Anodyne'), a leading provider of lifestyle-oriented clinical footwear solutions most commonly prescribed for diabetic patients.

Considered in this report

• Historic year: 2018
• Base year: 2023
• Estimated year: 2024
• Forecast year: 2029

Aspects covered in this report

• Diabetic Footwear market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Products

• Shoes
• Slippers
• Sneakers
• Sandals
• Others (Socks)

By Foot Condition

• Neuropathy
• Ulcers
• Deformities

By Distribution Channel

• Specialty Stores
• Hypermarket / supermarket
• Online Platform
• Others (Pharmacy store, Brand Outlets)

By End User

• Men
• Women

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Diabetic Footwear industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.


This product will be delivered within 2 business days.